Works matching IS 14655411 AND DT 2025 AND VI 27 AND IP 1

Results: 141
    1

    Ipatasertib combined with non-taxane chemotherapy for patients with previously treated advanced triple-negative breast cancer: the PATHFINDER phase IIa trial.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02089-4
    By:
    • López-Miranda, Elena;
    • Pérez-García, Jose Manuel;
    • Gión, María;
    • Ribelles, Nuria;
    • Cortez-Castedo, Patricia;
    • Alonso-Romero, José Luis;
    • García, María Martínez;
    • González-Santiago, Santiago;
    • Bermejo, Begoña;
    • Morales, Serafín;
    • Carañana, Vicente;
    • Garrigós, Laia;
    • Fernández-Pinto, Melissa;
    • García-Vicente, Silvia;
    • Garcia-Sanz, Alicia;
    • Mena-Molina, Arnau;
    • Boix, Olga;
    • Alcalá-López, Daniel;
    • Llombart-Cussac, Antonio;
    • Cortés, Javier
    Publication type:
    Article
    2
    3
    4
    5
    6

    Retinoic acid-induced 2 deficiency impairs genomic stability in breast cancer.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02085-8
    By:
    • Boettcher, Lena;
    • Greimeier, Sarah;
    • Borgmann, Kerstin;
    • Mughal, Shabbir S.;
    • Ellinger, Bernhard;
    • Bartkowiak, Kai;
    • Zobiak, Bernd;
    • Failla, Antonio V.;
    • Steffen, Pascal;
    • Claus, Ellen;
    • Besler, Katharina;
    • Buccitelli, Christopher;
    • Schaaf, Violetta;
    • Ozga, Ann-Kathrin;
    • Parretta, Simona;
    • Schneegans, Svenja;
    • Mansour, Wael Y.;
    • Korbel, Jan O.;
    • Schlueter, Hartmut;
    • Brors, Benedikt
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Overexpression of TSG101 causes the development of adenosquamous mammary carcinoma.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02007-8
    By:
    • Dennaoui, Rayane;
    • Rädler, Patrick D.;
    • Wicker, Madison N.;
    • Vistisen, Kerry;
    • Ferraiuolo, Rosa‑Maria;
    • Triplett, Aleata A.;
    • Shrestha, Hridaya;
    • Liner, Tessa A.;
    • Manthey, Karoline C.;
    • Rui, Hallgeir;
    • Cardiff, Robert D.;
    • Gunn, Teresa M.;
    • Perou, Charles M.;
    • Wagner, Kay-Uwe
    Publication type:
    Article
    19
    20
    21
    22

    A comparative study of four cell-free DNA assays for detecting circulating tumor DNA in early breast cancer.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02077-8
    By:
    • Mulder, Charlotta V.;
    • Jongbloed, Elisabeth M.;
    • Liefaard, Marte C.;
    • Makrodimitris, Stavros;
    • Hazelaar, Daan M.;
    • Beaufort, Corine M.;
    • de Weerd, Vanja;
    • Mulder, Lennart;
    • van Deurzen, Carolien H.M.;
    • Sonke, Gabe S.;
    • Jager, Agnes;
    • Wilting, Saskia M.;
    • Martens, John W.M.;
    • Jansen, Maurice P.H.M.;
    • Lips, Esther H.
    Publication type:
    Article
    23

    Cancer-associated fibroblast driven paracrine IL-6/STAT3 signaling promotes migration and dissemination in invasive lobular carcinoma.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02074-x
    By:
    • Bullock, Esme;
    • Rozyczko, Aleksandra;
    • Shabbir, Sana;
    • Tsoupi, Ifigenia;
    • Young, Adelaide I.J.;
    • Travnickova, Jana;
    • Gómez-Cuadrado, Laura;
    • Mabruk, Zeanap;
    • Carrasco, Giovana;
    • Morrow, Elizabeth;
    • Pennel, Kathryn;
    • Kloosterman, Pim;
    • Houthuijzen, Julia M;
    • Jonkers, Jos;
    • Avalle, Lidia;
    • Poli, Valeria;
    • Iggo, Richard;
    • Xiao, Xue;
    • Guo, Jingjing;
    • Zhu, Xuan
    Publication type:
    Article
    24
    25
    26
    27

    Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2− advanced or metastatic breast cancer: phase 1/2 study results.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02049-y
    By:
    • Hamilton, Erika P.;
    • Patel, Manish R.;
    • Borges, Virginia F.;
    • Meisel, Jane L.;
    • Okera, Meena;
    • Alemany, Carlos A.;
    • Pluard, Timothy J.;
    • Wesolowski, Robert;
    • Sabanathan, Dhanusha;
    • Miller, Kathy D.;
    • Conlin, Alison K.;
    • McCarthy, Nicole;
    • Shaw, Morena;
    • Tonda, Margaret;
    • Shilkrut, Mark;
    • Lin, Nancy U.
    Publication type:
    Article
    28
    29
    30

    Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trial.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02070-1
    By:
    • Leon-Ferre, Roberto A.;
    • Dimitroff, K.;
    • Yau, C.;
    • Giridhar, K. V.;
    • Mukhtar, R.;
    • Hirst, G.;
    • Hylton, N.;
    • Perlmutter, J.;
    • DeMichele, A;
    • Yee, D;
    • van 't Veer, L;
    • Rugo, H;
    • Symmans, W. F.;
    • Goetz, M. P.;
    • Esserman, L.;
    • Boughey, J. C.
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37

    Anti-cancer drug sensitivity testing and preclinical evaluation of the anti-cancer potential of WEE1 inhibitor in triple-negative breast cancer patient-derived organoids and xenograft models.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02063-0
    By:
    • Ryu, Seungyeon;
    • Kim, Hoe Suk;
    • Lee, Sangeun;
    • Yoon, So-Hyun;
    • Baek, Moonjou;
    • Park, A Young;
    • Lee, Han-Byoel;
    • Kim, Ga Yeon;
    • Park, Kyung Hyeun;
    • Jung, Ji-Jung;
    • Han, Yireh;
    • Lee, Dong Woo;
    • Ku, Bosung;
    • Han, Wonshik
    Publication type:
    Article
    38

    Hope for OTHERS (Our Tissue Helping Enhance Research & Science): research results from the University of Pittsburgh rapid autopsy program for breast cancer.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02014-9
    By:
    • Chang, Alexander Chih-Chieh;
    • Balic, Marija;
    • Bartholow, Tanner;
    • Bhargava, Rohit;
    • Brown, Daniel D.;
    • Brown, Lauren;
    • Brufsky, Adam;
    • Cao, Ye;
    • Carleton, Neil;
    • Clark, Amanda M.;
    • Cody, Morgan;
    • Ding, Kai;
    • Deible, Christopher;
    • Elangovan, Ashuvinee;
    • Foldi, Julia;
    • Geisler, Daniel;
    • Hodgdon, Christine;
    • Howard, Naomi;
    • Li, Zheqi;
    • Liu, Jie Bin
    Publication type:
    Article
    39
    40
    41

    Two-dimensional analysis of plasma-derived extracellular vesicles to determine the HER2 status in breast cancer patients.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02056-z
    By:
    • Wilhelm, Alexis;
    • Flynn, Charlotte;
    • Hammer, Evelyn;
    • Roessler, Johannes;
    • Haller, Bernhard;
    • Napieralski, Rudolf;
    • Leuthner, Moritz;
    • Tosheska, Sanja;
    • Knoops, Kèvin;
    • Mathew, Anjusha;
    • Ciarimboli, Giuliano;
    • Kranich, Jan;
    • Flaskamp, Lavinia;
    • King, Siobhan;
    • Gevensleben, Heidrun;
    • Emslander, Quirin;
    • Pastucha, Anna;
    • Reisbeck, Mathias;
    • Rief, Lukas;
    • Bronger, Holger
    Publication type:
    Article
    42
    43

    Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02058-x
    By:
    • Van Baelen, Karen;
    • Nguyen, Ha-Linh;
    • Richard, François;
    • Zels, Gitte;
    • Karsten, Maria Margarete;
    • Nader-Marta, Guilherme;
    • Vermeulen, Peter;
    • Dirix, Luc;
    • Dordevic, Adam David;
    • de Azambuja, Evandro;
    • Larsimont, Denis;
    • Maetens, Marion;
    • Biganzoli, Elia;
    • Wildiers, Hans;
    • Smeets, Ann;
    • Nevelsteen, Ines;
    • Neven, Patrick;
    • Floris, Giuseppe;
    • Desmedt, Christine
    Publication type:
    Article
    44

    Correction: Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer.

    Published in:
    2025
    By:
    • Nokin, Marie-Julie;
    • Bellier, Justine;
    • Durieux, Florence;
    • Peulen, Olivier;
    • Rademaker, Gilles;
    • Gabriel, Maude;
    • Monseur, Christine;
    • Charloteaux, Benoit;
    • Verbeke, Lieven;
    • van Laere, Steven;
    • Roncarati, Patrick;
    • Herfs, Michael;
    • Lambert, Charles;
    • Scheijen, Jean;
    • Schalkwijk, Casper;
    • Colige, Alain;
    • Caers, Jo;
    • Delvenne, Philippe;
    • Turtoi, Andrei;
    • Castronovo, Vincent
    Publication type:
    Correction Notice
    45
    46

    Distribution of age at natural menopause, age at menarche, menstrual cycle length, height and BMI in BRCA1 and BRCA2 pathogenic variant carriers and non-carriers: results from EMBRACE.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02030-9
    By:
    • Mavaddat, Nasim;
    • Frost, Debra;
    • Zhao, Emily;
    • Barnes, Daniel R.;
    • Ahmed, Munaza;
    • Barwell, Julian;
    • Brady, Angela F.;
    • Brennan, Paul;
    • Conti, Hector;
    • Cook, Jackie;
    • Copeland, Harriet;
    • Davidson, Rosemarie;
    • Donaldson, Alan;
    • Douglas, Emma;
    • Gallagher, David;
    • Hart, Rachel;
    • Izatt, Louise;
    • Kemp, Zoe;
    • Lalloo, Fiona;
    • Miedzybrodzka, Zosia
    Publication type:
    Article
    47
    48
    49
    50